Hamilton Health Sciences Corporation

Several studies address atrial fibrillation across different clinical settings, including episodes triggered by stress, patients requiring anticoagulation, and those at elevated risk after intracranial hemorrhage. The research also covers anticoagulant use after cardiac surgery and in patients with complex thromboembolic risk profiles.

• Atrial fibrillation
• Stroke prevention
• Anticoagulation

Clinical interest includes the balance between preventing systemic embolism and reducing bleeding-related complications in high-risk populations.

The sponsor supports research in patients with mechanical bileaflet aortic valve replacement who require vitamin K antagonist therapy. This area reflects attention to long-term anticoagulation management in valve-related thrombosis prevention while considering bleeding risk.

• Mechanical aortic valves
• Vitamin K antagonist therapy
• Bleeding risk

Work in this domain is centered on achieving safer anticoagulation strategies for patients with prosthetic heart valves.

Research includes patients undergoing total joint replacement, particularly hip and knee procedures, with emphasis on preventing postoperative infection and avoiding reoperation. The sponsor’s interest spans both primary and revision surgery settings.

• Total joint replacement
• Hip and knee surgery
• Infection prophylaxis

Therapeutic attention is directed toward local infection-control strategies in orthopaedic care.

The portfolio also explores colchicine and thiamine in cardiovascular conditions, reflecting interest in anti-inflammatory and supportive approaches for heart failure and vascular disease. These studies connect systemic inflammation, cardiac function, and prevention of adverse cardiovascular outcomes.

• Colchicine
• Thiamine
• Adjunctive cardiovascular therapy

Clinical activity in this area links symptom reduction with broader cardiovascular protection.